Mepolizumab is indicated for adults and children aged 12 years and older with HES for 6 months or longer without an identifiable nonhematologic secondary cause.
FDA Approvals
…read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
